Observational studyScientific reports2022

Time course of changes in vision-related quality of life following intravitreal ranibizumab treatment for branch retinal vein occlusion.

Shohei Morikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.